digestion: always trust your gut

Did you know that your gut has around 10-14 bacteria, comprised of more than a thousand species? (1-2)

Over the last decades, it has become clear that the diverse micro organisms that live in the digestive tract play a significant role in human health or disease (3). Numerous studies show the beneficial effects of nutrition or biochemical compounds on gut microbiota or its host (4). Your diet and nutrition undoubtedly influences the composition of your gut microbiota (5).

But your microbiota also influences you:
Individual composition of gut microbiota differs immensely, partially based on genetics and diet: while some possess bacteria mostly associated with pro-inflammatory effects, others may contain those with anti-inflammatory effects (6). Accordingly, the micro organisms in your digestive tract are important for the development of your overal immune system (7).

In general, inflammatory processes that alter gut macrobiotic play a key role in many diseases such as diabetes, cardiovascular disease, Parkinson's, Alzheimer's, and many others (8).

So how do we improve our nutrition in the most natural way? Here is where the nutrients in Marine Phytoplankton can play an essential role.

Marine Phytoplankton is the fundament of the entire food chain. With the aid of sunlight it harnesses a great amount of nutrients from the environment. This is called photosynthesis.

This process is eventually channeling these essential nutritional compounds towards krill, fish, mammals, and even humans (9). Marine Phytoplankton contains 10% carbohydrates, 47-52% protein, 18-20% lipids and 15-18% dietary fiber. On top of that, it contains essential minerals and vitamins as well (10-12). These numbers vary due to seasonal differences in eventual Phytoplankton growth condition and differentiation.

Carbohydates are the main component in the Phytoplankton cell wall. Besides being a vital structural component, carbohydrates can also be used to deliver energy. These carbohydrates in Marine Phytoplankton are glycose, galactose and mannose (13).

Among these carbohydrates, polysaccharides seem to be the most promising. 

These polysaccharides can be found in Marine phytoplankton: the compounds have the potential to beneficially affect its host by selectively stimulation activity or growth of certain bacteria in the gut (14). As a result, different types of algae have successfully been incorporated into yogurts, cheeses for example because it improves the viability of probiotics. On top of that, many other products - bread, cookies, etc - use it to enhance its protein and fibre content (15). Edible algae contain extraordinary high amount of dietary fiber: fiber is responsible for regulating transit time in the gastro-intestinal tract (16).

Increasing your fiber intake is a first step in the treatment of constipation (17).

Fiber from algae has also been used for treatment of several gastro-intestinal disorders, such as diarrhea and ulcerative colitis (18-20).

Studies show that the specific bioactive compounds, trace elements, and vitamins of algae can stimulate the growth of desires probiotic bacteria (21-25).

The lipids from marine phytoplankton aid in digestion, provide energy, are a vital structure in cell membranes, and posses many other functions (26).



Your stomach is constantly exposed to varying severe inflammations to digest our food and protect us against pathogens. Problems with our digestion, stomach and stool are partially caused be infections and associated oxidative stress (27).

The antioxidants in Marine Phytoplankton, such as beta-carotene, omega-3 fatty acids, etc. - can decrease the severity of these inflammatory responses. 

Adding plnktn. can support gastric health and has been reported to decrease clinical symptoms of constipation, bloating, flatulence, abdominal pain, indigestion, nausea, reflux, etc. (28-34).

The omega-3 fatty acids

O3FAs posses anti-inflammatory properties, and supplementation has shown beneficial effect against inflammatory bowel disease (35). These fatty-acids seem to be promising components with potential probiotic applications (36-38). Marine phytoplankton also contains a high protein, vitamin, and mineral content (39).



plnktn. contains vital minerals, which are essential for most living organisms, such as the bacteria in our gut. When we ingest Marine Phytoplankton, the vast amount of minerals become available to the microbes in our gut. Depending on the taxonomic group, physiological and season variation, it can contain a great abundance of magnesium, sodium, calcium, potassium, sulfate, chloride, and micronutrients such as iron, iodine, zinc, copper, selenium, fluoride, etc. (43,44).


So why do they tell you to "follow your gut"?

There seems to be a direction connection between gut microbiota, heart, brain, and many other organs (45). According to research the gut has direct influence on cognitive functioning, such as seen in depression and even on cardiovascular health, such as hypertension (46).

Did you ever experience stomach problems when feeling anxiety or stress?

Positive influencing your gut microbiota has been proposed as part of various treatments for years, and exciting results have been seen so far.

We will discuss this ongoing research in more depth in future posts.


Adding plnktn. to your daily nutrition might have positive influences in the microbiota of your gut. It might also improve your symptoms of gastrointestinal problems. So far, we have noticed that many clients experience positive effects with regards to their digestion.

However, plnktn. is not a replacement for your medication. Always consult your or our doctor before taking Marine Phytoplankton as a replacement for other medicine.



Marine Phytoplankton, an "all-in-one" superfood full of natural nutrients. 

Besides being the source of Omega-3 fatty acids, Marine Phytoplankton is rich in vitamins minerals and strong antioxidants. 

The perfect supplementation to your daily nutritional needs. Discover it now:

shop now

Please click below to see which scientific articles were used to gather information concerning the subject.

Click here

(1). Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Humanand Bacteria Cells in the Body. PLoS Biol. 2016 Aug 19;14(8):e1002533. doi:10.1371/journal.pbio.1002533. PMID: 27541692; PMCID: PMC4991899.


(2). Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, PonsN, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, LiangH, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le PaslierD, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, TurnerK, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, WangJ, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J,Weissenbach J; MetaHIT Consortium, Bork P, Ehrlich SD, Wang J. A human gutmicrobial gene catalogue established by metagenomic sequencing. Nature. 2010 Mar 4;464(7285):59-65. doi:10.1038/nature08821. PMID: 20203603; PMCID: PMC3779803.


(3). de Jesus Raposo MF, de Morais AM, de Morais RM. Emergent Sources of Prebiotics:Seaweeds and Microalgae. Mar Drugs. 2016 Jan 28;14(2):27. doi:10.3390/md14020027. PMID: 26828501; PMCID: PMC4771980.


(4). Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, Van ImmerseelF. From the gut to the peripheral tissues: the multiple effects of butyrate.Nutr Res Rev. 2010 Dec;23(2):366-84. doi: 10.1017/S0954422410000247. Epub 2010Oct 12. PMID: 20937167.


(5). Flint HJ, Duncan SH, Louis P. The impact of nutrition on intestinalbacterial communities. Curr Opin Microbiol. 2017 Aug;38:59-65. doi:10.1016/j.mib.2017.04.005. Epub 2017 May 6. PMID: 28486162.


(6). Al Bander Z, Nitert MD, Mousa A, Naderpoor N. The Gut Microbiota andInflammation: An Overview. Int J Environ Res Public Health.2020;17(20):7618. Published 2020 Oct 19. doi:10.3390/ijerph17207618


(7). Honda K, Littman DR. The microbiota in adaptive immune homeostasis anddisease. Nature. 2016 Jul7;535(7610):75-84. doi: 10.1038/nature18848. PMID: 27383982.


(8). Costantini L, Molinari R, Farinon B, Merendino N. Impact of Omega-3 FattyAcids on the Gut Microbiota. Int J Mol Sci. 2017;18(12):2645. Published2017 Dec 7. doi:10.3390/ijms18122645


(9). Jónasdóttir SH. Fatty Acid Profiles and Production in MarinePhytoplankton. Mar Drugs. 2019;17(3):151. Published 2019 Mar 4.doi:10.3390/md17030151


(10). Becker EW. Micro-algae as a source of protein. Biotechnol Adv. 2007 Mar-Apr;25(2):207-10. doi:10.1016/j.biotechadv.2006.11.002. Epub 2006 Nov 23. PMID: 17196357.


(11). Chronakis IS, Madsen M. Algal proteins. Handbook of food proteins.In: Phillips GO, Williams PA, editors. Woodhead Publishing Series in FoodSciences, Technology and Nutrition. (2011). p. 353–94.


(12). Wells ML, Potin P, Craigie JS, Raven JA, Merchant SS, Helliwell KE, SmithAG, Camire ME, Brawley SH. Algae as nutritional and functional food sources:revisiting our understanding. J Appl Phycol. 2017;29(2):949-982. doi:10.1007/s10811-016-0974-5. Epub 2016 Nov 21. PMID: 28458464; PMCID: PMC5387034.


(13). Brown M.R., Jeffrey S.W., Volkman J.K., Dunstan G. Nutritionalproperties of microaglae for mariculture. Aquaculture. 1997;151:315–331. doi:10.1016/S0044-8486(96)01501-3.


(14). Moreno JF, Corzo N, Montilla A, Villamiel M, Olano A. Currentstate and latest advances in the concept, production and functionality ofprebiotic oligosaccharides. Curr Opin Food Sci. (2017) 13:50–5.10.1016/j.cofs.2017.02.009


(15). Singh P, Singh R, Jha A, Rasane P, Gautam AK. Optimization of a process forhigh fibre and high protein biscuit. J Food Sci Technol. 2015Mar;52(3):1394-403. doi: 10.1007/s13197-013-1139-z. Epub 2013 Aug 15. PMID:25745207; PMCID: PMC4348284.


(16). EmergentSources of Prebiotics: Seaweeds and Microalgae. de Jesus Raposo MF,de Morais AM, de Morais RM Mar Drugs. 2016 Jan 28; 14(2)


(17). Lembo A, Camilleri M. Chronic constipation. N Engl J Med. 2003 Oct2;349(14):1360-8. doi: 10.1056/NEJMra020995. PMID: 14523145.


(18). McRorie JW, Daggy BP, Morel JG, Diersing PS, Miner PB, Robinson M. Psylliumis superior to docusate sodium for treatment of chronic constipation. AlimentPharmacol Ther. 1998 May;12(5):491-7. doi: 10.1046/j.1365-2036.1998.00336.x.PMID: 9663731.


(19). Mehmood MH, Aziz N, Ghayur MN, Gilani AH. Pharmacological basis for themedicinal use of psyllium husk (Ispaghula) in constipation and diarrhea. DigDis Sci. 2011 May;56(5):1460-71. doi: 10.1007/s10620-010-1466-0. Epub 2010 Nov17. PMID: 21082352.


(20). Fernández-Bañares F, Hinojosa J, Sánchez-Lombraña JL, Navarro E,Martínez-Salmerón JF, García-Pugés A, González-Huix F, Riera J, González-LaraV, Domínguez-Abascal F, Giné JJ, Moles J, Gomollón F, Gassull MA. Randomizedclinical trial of Plantago ovata seeds (dietary fiber) as compared withmesalamine in maintaining remission in ulcerative colitis. Spanish Group forthe Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Am JGastroenterol. 1999 Feb;94(2):427-33. doi: 10.1111/j.1572-0241.1999.872_a.x.PMID: 10022641.

(21). Cho EJ, Nam ES, Park SI. Keeping quality and sensory properties ofdrinkable yoghurt with added Chlorella extract. Korean J Food Nutr. (2004)17:128–32


(22). Jeon JK. Effect of Chlorella addition on the quality of processedcheese. J Korean Soc Food Sci Nutr. (2006) 35:373–7. 10.3746/jkfn.2006.35.3.373


(23). Varga L, Szigeti J, Kovács R, Földes T, Buti S. Influence of a Spirulinaplatensis biomass on the microflora of fermented ABT milks during storage (R1).J Dairy Sci. 2002 May;85(5):1031-8. doi: 10.3168/jds.S0022-0302(02)74163-5.PMID: 12086036.


(24). Molnár N, Gyenis B, Varga L. Influence of a powdered Spirulinaplatensis biomass on acid production of lactococci in milk. Milchwissenschaft (2005) 60:380–382.


(25). Parada JL, Zulpa de Caire G, Zaccaro de Mulé MC,Storni de Cano MM. Lactic acid bacteria growth promoters from Spirulina platensis. Int J FoodMicrobiol. 1998 Dec 22;45(3):225-8. doi: 10.1016/s0168-1605(98)00151-2. PMID:9927000.


(26). Jónasdóttir SH. Fatty Acid Profiles and Production in MarinePhytoplankton. Mar Drugs.2019;17(3):151. Published 2019 Mar 4. doi:10.3390/md17030151


(27). Kupcinskas L, Lafolie P, Lignell A, Kiudelis G, Jonaitis L, Adamonis K,Andersen LP, Wadström T. Efficacy of the natural antioxidant astaxanthin in thetreatment of functional dyspepsia in patients with or without Helicobacterpylori infection: A prospective, randomized, double blind, andplacebo-controlled study. Phytomedicine. 2008 Jun;15(6-7):391-9. doi:10.1016/j.phymed.2008.04.004. Epub 2008 May 7. PMID: 18467083.


(28). Spagnuolo R, Cosco C, Mancina RM, Ruggiero G, Garieri P, Cosco V, Doldo P.Beta-glucan, inositol and digestive enzymes improve quality of life of patientswith inflammatory bowel disease and irritable bowel syndrome. Eur Rev MedPharmacol Sci. 2017 Jun;21(2 Suppl):102-107. PMID: 28724171.


(29). Vieira MV, Pastrana LM, Fuciños P. Microalgae Encapsulation Systems forFood, Pharmaceutical and Cosmetics Applications. Mar Drugs.2020;18(12):644. Published 2020 Dec 15. doi:10.3390/md18120644


(30). Vieira MV, Pastrana LM, Fuciños P. Microalgae Encapsulation Systems forFood, Pharmaceutical and Cosmetics Applications. Mar Drugs.2020;18(12):644. Published 2020 Dec 15. doi:10.3390/md18120644


(31). Wang X et al.Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infectionon BALB/cA mice. Antimicrob Agents Chemother 2000;44(9):2452-7.


(32). Nishikawa Y etal. Effects of astaxanthin and vitamin C on the prevention of gastriculcerations in stressed rats. J Nutr Sci Vitaminol (Tokyo). 2005;51(3):135-41.


(33). Kupcinskas L etal. Efficacy of the natural antioxidant astaxanthin in the treatment offunctional dyspepsia in patients with or without Helicobacter pylori infection:a prospective, randomized, double blind, and placebo-controlled study


(34). Kupcinskas et al. “Efficacy of astaxanthin, anatural antioxidant from algae, in the treatment of functional dyspepsia: aprospective, randomized, double blind, and placebo-controlled study” (2009): Medicina/Medicine.p. 415-416

(35). Calder PC. Fatty acids and immune function: relevanceto inflammatory bowel diseases. Int Rev Immunol. 2009;28(6):506-34. doi:10.3109/08830180903197480. PMID: 19954361.


(36). de Jesus Raposo MF, de Morais AM, de Morais RM.Emergent Sources of Prebiotics: Seaweeds and Microalgae. Mar Drugs. 2016 Jan28;14(2):27. doi: 10.3390/md14020027. PMID: 26828501; PMCID: PMC4771980.

(37). MorenoJF, Corzo N, Montilla A, Villamiel M, Olano A. Current state and latestadvances in the concept, production and functionality of prebioticoligosaccharides. Curr Opin Food Sci. (2017) 13:50–5.10.1016/j.cofs.2017.02.009

(38). Jutur PP, Nesamma AA,Shaikh KM. Algae-derived marine oligosaccharides and their biologicalapplications. Front Mar Sci. (2016) 3:83 10.3389/fmars.2016.00083

(39). Safi C., Zebib B., MerahO., Pontalier P.Y., Vaca-Garcia C. Morphology, composition, production,processing and applications of Chlorella vulgaris: A review. Renew. Sustain.Energy Rev. 2014;35:265–278. doi: 10.1016/j.rser.2014.04.007

(40). Lubitz J. The protein quality, digestibililty andcomposition of algae, Chlorella 71105. J Food Sci. 1963;28:229–241. doi:10.1111/j.1365-2621.1963.tb00189.x

(41). Gantar M, Svirčev Z. MICROALGAE AND CYANOBACTERIA: FOOD FOR THOUGHT(1). JPhycol. 2008 Apr;44(2):260-8. doi: 10.1111/j.1529-8817.2008.00469.x. PMID:27041182.

(42). Szabo NJ, Matulka RA, Chan T. Safetyevaluation of Whole Algalin Protein (WAP) from Chlorella protothecoides. FoodChem Toxicol. 2013 Sep;59:34-45. doi: 10.1016/j.fct.2013.05.035. Epub 2013 Jun1. PMID: 23733102.

(43). MabeauS., Fleurence J. Seaweed in food products: Biochemical and nutritional aspects.Trends Food Sci. Technol. 1993;4:103–107. doi: 10.1016/0924-2244(93)90091-N.

(44). Lorenzo JM, Agregán R, Munekata PES, Franco D, Carballo J, Şahin S, LacombaR, Barba FJ. Proximate Composition and Nutritional Value of Three Macroalgae:Ascophyllum nodosum, Fucus vesiculosus and Bifurcaria bifurcata. Mar Drugs.2017 Nov 15;15(11):360. doi: 10.3390/md15110360. PMID: 29140261; PMCID:PMC5706049.

(45). Sampson TR, Mazmanian SK. Control of brain development, function, andbehavior by the microbiome. Cell Host Microbe. 2015 May 13;17(5):565-76. doi:10.1016/j.chom.2015.04.011. PMID: 25974299; PMCID: PMC4442490.

(46). Vallianou NG, Geladari E, Kounatidis D. Microbiome and hypertension: whereare we now? J Cardiovasc Med(Hagerstown). 2020 Feb;21(2):83-88. doi: 10.2459/JCM.0000000000000900. PMID:31809283.